Original Research Article I Volume 5 I Issue 4 I 2017

Correlation between the incidence and severity of Aortic Valve Calcific Stenosis and Carotid Atherosclerosis

Samir Rafla; Sahar Hamdy; Mohamed Loutfy; Mohamed Elneklawy

Biolife; 2017, 5(4), pp 538-543

DOI:https://doi.org/10.5281/zenodo.7393117

Abstract:

Background: Aortic valvular calcification (AVC) and carotid arterial disease (CaAD) have a high prevalence in elderly patients (pts). Aim of the work: To study the severity and relation of carotid plaques and coronary atherosclerotic lesions (CAD) in pts with calcific aortic sclerosis/stenosis.

Keywords:

Carotid plaques, aortic calcific stenosis, intima media thickness, coronary heart disease.

References:

  1. Otto CM, Lind BK, Kitzman DW, et al. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 2000; 341:142-7.
  2. Aronow WS, Ahn C, Shirani J, et al. Comparison of frequency of new coronary events in older subjects with and without valvular aortic sclerosis. Am J Cardiol 1999; 83: 599-600.
  3. Budoff MJ, Shavelle DM, Lamont DH, et al. Usefulness of electron beam computed tomography scanning for distinguishing ischemic from nonischemic cardiomyopathy. J Am Coll Cardiol 1998; 32: 1173-8.
  4. Selzer A. changing aspects of Natural History of valvular aortic stenosis N Engl J Med 1987; 317: 91-8.
  5. O’Brien KD, Kuusisto J, Reichenbach DD, et al. Osteopontin is expressed in human aortic valvular lesions. Circulation 1995; 92: 2163-8.
  6. Shavelle DM, Takasu J, Budoff MJ, et al. HMG CoA reductase inhibitor (Statin) and aortic valve calcium. Lancet 2002; 359: 1125-6.
  7. Pohle K, Maffert R, Ropers D, et al. Progression of aortic valve calcification: association with coronary atheroscerlosis and cardiovascular risk factors. Circulation 2001; 104: 1927-32.
  8. Novaro GM, Tiong IY, Pearce GL, et al. Effect of hydroxymethylglutaryl coenzyme A reductase inhibitors on the progression of calcific aortic stenosis. Circulation 2001; 104: 2205-9.
  9. Anne B. Rossebø, MD, Terje R. Pedersen, MD, Christopher Allen, et al. Design and Baseline Characteristics of the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Study. The American Journal of CardiologyVolume 99, Issue 7, 1 April 2007, Pages 970–973
  10. S. Joanna Cowell, B.M., David E. Newby, M.D., Robin J. Prescott, Ph.D. et al. for the Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression (SALTIRE) Investigators.  A Randomized Trial of Intensive Lipid-Lowering Therapy in Calcific Aortic Stenosis. N Engl J Med 2005;352:2389-97.
  11. Adams MR, Nakagomi A, Keech A, et al. Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease. Circulation 1995; 92(8): 2127-34.
  12. Salonen JT, Salonen R. Ultrasongraphically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 1991; 11: 1245-9.

Article Dates:

Received: 3 October 2017; Accepted: 23 November 2017; Published: 4 December 2017

How To Cite:

Samir Rafla, Sahar Hamdy, Mohamed Loutfy, & Mohamed Elneklawy. (2022). Correlation between the incidence and severity of Aortic Valve Calcific Stenosis and Carotid Atherosclerosis. Biolife, 5(4), 538–543. https://doi.org/10.5281/zenodo.7393117

Download Full Paper: PDF

Logo


Logo